UK MHRA grapples with ATMP complexities and asks for comments
This article was originally published in Clinica
Executive Summary
The complexities of regulating advanced therapy medicinal products at the national level in compliance with the EU’s ATMP Regulation, due to apply in member state law as of this December 30, are becoming clear now that the national authorities are rising to the challenge of the necessary steps to implement the Regulation.